Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2022-05-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 텔콘알에프제약' covering the period from 2022-01-01 to 2022-03-31. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-05-06 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Telcon RF Pharmaceutical) detailing the adjustment of the conversion price for convertible bonds (CBs). This type of disclosure is a standard corporate action related to capital structure and financing instruments. Since it specifically addresses changes to the terms of existing financial instruments (convertible bonds) rather than a new share issuance or a general regulatory announcement, it falls under the 'Capital/Financing Update' category.
2022-05-02 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Telcon RF Pharmaceutical regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2022-04-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership, including the acquisition of convertible bonds and subsequent conversion into shares by the major shareholder, Hanil Vacuum, in Telcon RF Pharmaceutical. This falls under the category of Major Shareholding Notification.
2022-04-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure for insiders (executives and major shareholders) regarding changes in their shareholdings, which falls under the category of 'Director's Dealing' (DIRS) as it tracks insider transactions and ownership status.
2022-04-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.